ABECMA Trademark
ABECMA is a USPTO trademark filed by Celgene Corporation. Status: Registered.
Prosecution Summary
**Trademark Summary** **ABECMA** is a standard character service mark for medical treatment services in the fields of multiple myeloma, cancer, and oncology diseases, plus provision of medical information and data for diagnosis and treatment in International Class 044. The mark is owned by **Celgene Corporation**, a Delaware corporation headquartered at 86 Morris Ave, Summit, New Jersey 07901. It is currently **registered** on the Principal Register (Registration No. 6847538) since September 13, 2022, with first use in commerce on March 26, 2021. No notable issues or legal proceedings are present. **Recent Activity** Filed on November 5, 2020, the application faced a non-final office action on April 19, 2021, followed by applicant's response and approval for publication on October 21,
Trademark Facts
| Mark | ABECMA |
|---|---|
| Serial Number | 90300795 |
| Registration Number | 6847538 |
| Status | Registered |
| Filing Date | 2020-11-05 |
| Registration Date | 2022-09-13 |
| Mark Type | Word |
| Nice Classes | 044 (Medical Services) |
| Owner | Celgene Corporation |
| Attorney of Record | Marilyn F. Kelly |
| Prosecution Events | 22 |
| Latest Event | NRCC on 2022-09-13 |
Goods & Services
Medical treatment services in the fields of multiple myeloma, cancer, and diseases in the fields of oncology; provision of medical information and data for diagnosis and medical treatment